#190: ESC on anticoagulants; FDA on Liptruzet; Midei suit; MitraClip




This week in cardiology from heartwire show

Summary: For the week ending May 10, 2013 we discuss the following top cardiology news from heartwire: • ESC issues "practical guide" to new oral anticoagulants in AF • FDA approves atorvastatin/ezetimibe combo tablet • Midei malpractice suit settled before hearing Midei's testimony • No advantages, more surgery, with MitraClip at four years: EVEREST II And also, in brief: • Lancet antitobacco series launches as ACC chides FDA inaction • Stopping dabigatran ups stroke risk: New boxed warning Join us for a comprehensive review of this week's most important cardiology news.